Abiraterone Acetate

• Abiraterone Acetate is an androgen biosynthesis inhibitor used to treat prostate cancer.
• It works by blocking an enzyme (CYP17) essential for androgen production, thereby reducing testosterone levels.
• The medication is prescribed for metastatic castration-resistant prostate cancer and metastatic high-risk castration-sensitive prostate cancer.
• Common side effects include hypertension, hypokalemia, and fluid retention, often managed with concurrent prednisone.
• It must be taken on an empty stomach, and adherence to prescribed dosage and administration instructions is critical.

What is Abiraterone Acetate?

Abiraterone Acetate is an oral medication classified as an androgen biosynthesis inhibitor. It is specifically designed to treat prostate cancer by reducing the production of androgens (male hormones), including testosterone, which fuel the growth of prostate cancer cells. This medication is often used in combination with prednisone, a corticosteroid, to manage potential side effects related to mineralocorticoid excess.

How Abiraterone Acetate Works and Its Clinical Uses

Abiraterone Acetate functions by inhibiting an enzyme called cytochrome P450 17α-hydroxylase/C17,20-lyase (CYP17). This enzyme is critical in the biosynthesis of androgens in the testes, adrenal glands, and prostate tumor tissue itself. By blocking CYP17, Abiraterone Acetate significantly lowers androgen levels throughout the body, thereby slowing or stopping the growth of hormone-sensitive prostate cancer cells. This mechanism is distinct from traditional androgen deprivation therapy (ADT) which primarily targets testicular androgen production.

This medication is used for prostate cancer treatment in several contexts. It is indicated for patients with metastatic castration-resistant prostate cancer (mCRPC), a form of the disease that has spread to other parts of the body and continues to progress despite medical or surgical castration. Additionally, it is approved for the treatment of metastatic high-risk castration-sensitive prostate cancer (mCSPC), where the cancer has spread but still responds to hormone therapy. Prostate cancer is a significant health concern globally; for instance, it is the second most common cancer in men worldwide, with an estimated 1.4 million new cases diagnosed in 2020, according to the World Health Organization (WHO).

Abiraterone Acetate: Side Effects and Administration

Like all medications, Abiraterone Acetate can cause side effects. Understanding these and adhering to proper administration guidelines is crucial for patient safety and treatment efficacy. The most common abiraterone acetate side effects are often related to its impact on hormone levels and include:

• Hypertension (high blood pressure)
• Hypokalemia (low potassium levels)
• Fluid retention and edema
• Fatigue
• Joint swelling or discomfort
• Hot flashes
• Diarrhea

More serious, though less common, side effects can include hepatotoxicity (liver damage) and adrenal insufficiency. Regular monitoring of blood pressure, potassium levels, and liver function tests is essential during treatment to detect and manage these issues promptly. The concurrent use of prednisone helps mitigate some of the mineralocorticoid-related side effects.

Regarding abiraterone acetate dosage and administration, it is typically taken orally once daily. It is critical that the medication is taken on an empty stomach, at least one hour before or two hours after food. Food can significantly increase the absorption of Abiraterone Acetate, leading to higher drug levels and potentially increased side effects. Patients should not crush or chew the tablets. The prescribed dose of prednisone or methylprednisolone should also be taken as directed by the healthcare provider to help manage adverse effects and improve treatment outcomes. Patients must follow their doctor’s instructions precisely and report any new or worsening symptoms.